Clinical Trials Directory

Trials / Completed

CompletedNCT03922074

Outcomes of Colonoscopy With Non-anesthesiologist Administered Propofol

Outcomes of Colonoscopy With Non-anesthesiologist Administered Propofol. An Equivalence Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
630 (actual)
Sponsor
Serveis de Salut Integrats Baix Empordà · Academic / Other
Sex
All
Age
50 Years – 69 Years
Healthy volunteers
Not accepted

Summary

The Efficacy and safety of Non-anesthesiologist administered propofol (NAAP) for gastrointestinal endoscopy have been widely documented although there is not information which has evaluated the outcomes of colonoscopy it self when the endoscopist has to fulfill the additional task of supervising the sedation. Objective: To determine the equivalence of adenoma detection rate (ADR) in colorectal cancer (CRC) screening colonoscopies performed with NAAP and performed with monitored anesthesia care (MAC). Method: Single blind non-randomized controlled equivalence trial. Patients: Adults between 50 - 69 years old from National CRC screening program (CRCSP). Intervention: The patients are blindly assigned to undergo either colonoscopy with NAAP or MAC according to the arrival of fecal occult blood test, patient's suitability for colonoscopy date and availability of places at endoscopy schedule (with NAAP or MAC).

Conditions

Interventions

TypeNameDescription
PROCEDURESedation directed by an endoscopistThe nurse begins with fentanyl infusion in bolus: 75 μg (1.5 ml) and initial propofol dose (10mg/ml) in bolus of 0.5 - 2.5 mg/Kg followed by a maintenance dose of 20 - 60ml/h through Target-controlled infusion (TCI) pump. In this way, we get a target level sedation between 1 - 3, according to Observer's Assessment of Alertness/Sedation Scale (OAAS). The role of the nurse, directed by an endoscopist, it is exclusively the administration of intravenous drugs and the patient monitorship throughout the procedure.
PROCEDURESedation directed by an anesthesiologistThe choice of the drugs and the target level sedation are directed by an anesthesiologist

Timeline

Start date
2017-01-02
Primary completion
2018-12-31
Completion
2019-12-31
First posted
2019-04-19
Last updated
2020-09-16

Source: ClinicalTrials.gov record NCT03922074. Inclusion in this directory is not an endorsement.